Prospective Validation Study of the CD8+TEMRA Cells As a Prognostic Biomarker of Healing Outcome After Fracture
Clinical trial NCT06658379 · RECRUITING
Trial details
- NCT number
- NCT06658379
- Sponsor
- Charite University, Berlin, Germany
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-01
- Primary completion
- 2025-04-01
- Enrollment
- 640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.